These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12010235)

  • 1. Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease.
    Cavallini G; Biagiotti G; Koverech A; Vitali G
    BJU Int; 2002 Jun; 89(9):895-900. PubMed ID: 12010235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
    Cavallini G; Modenini F; Vitali G
    Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study.
    Safarinejad MR; Hosseini SY; Kolahi AA
    J Urol; 2007 Oct; 178(4 Pt 1):1398-403; discussion 1403. PubMed ID: 17706714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards an evidence-based understanding of Peyronie's disease.
    Cavallini G
    Int J STD AIDS; 2005 Mar; 16(3):187-94; quiz 94-5. PubMed ID: 15829017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
    Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
    Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
    Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
    Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report.
    Biagiotti G; Cavallini G
    BJU Int; 2001 Jul; 88(1):63-7. PubMed ID: 11446848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
    Greenfield JM; Shah SJ; Levine LA
    J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
    Rehman J; Benet A; Melman A
    Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
    Asali M; Asali M
    Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical analysis of nonsurgical treatment of Peyronie's disease.
    Hauck EW; Diemer T; Schmelz HU; Weidner W
    Eur Urol; 2006 Jun; 49(6):987-97. PubMed ID: 16698449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.
    Shirazi M; Haghpanah AR; Badiee M; Afrasiabi MA; Haghpanah S
    Int Urol Nephrol; 2009; 41(3):467-71. PubMed ID: 19199072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with intraplaque injection of verapamil for Peyronie's disease.
    Levine LA; Goldman KE; Greenfield JM
    J Urol; 2002 Aug; 168(2):621-5; discussion 625-6. PubMed ID: 12131321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Management of Peyronie's Disease.
    Trost LW; Gur S; Hellstrom WJ
    Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease.
    Mehrsai AR; Namdari F; Salavati A; Dehghani S; Allameh F; Pourmand G
    Andrology; 2013 Jan; 1(1):129-32. PubMed ID: 23258641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
    Alizadeh M; Karimi F; Fallah MR
    Glob J Health Sci; 2014 Sep; 6(7 Spec No):23-30. PubMed ID: 25363175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
    Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
    J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional verapamil injection for the treatment of Peyronie's disease.
    Levine LA; Merrick PF; Lee RC
    J Urol; 1994 Jun; 151(6):1522-4. PubMed ID: 8189561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
    Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
    Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional verapamil prevents the progression of Peyronie's disease.
    Bennett NE; Guhring P; Mulhall JP
    Urology; 2007 Jun; 69(6):1181-4. PubMed ID: 17572211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.